About: Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia Goto Sponge NotDistinct Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

Attributes	Values
rdf:type	skos:Concept http://linked.opendata.cz/ontology/domain/vavai/Vysledek
Description	V této randomizované studii III skupiny EORTC Leukemia Cooperative Group je analyzováno léčení pacientů s MDS s poruchou krvetvorby v 10-30%. (cs) In this randomized phase III study of the EORTC Leukemia Cooperative Group, treatemet of patients with myelodysplastic syndromes (MDS) with 10-30% bone marrow blasts and hematopoietic failure is analyzed. In this randomized phase III study of the EORTC Leukemia Cooperative Group, treatemet of patients with myelodysplastic syndromes (MDS) with 10-30% bone marrow blasts and hematopoietic failure is analyzed. (en)
Title	Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia Léčba pomocí nízkých dávek cytosinu arabinoside (LD-AraC) vs LD-AraC plus granulocytů / makrofágů vs LD-AraC plus interleukinu-3 u MDS u pacientů s vysokým rizikem vývoje akutní leukémie. (cs) Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia (en)
skos:prefLabel	Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia Léčba pomocí nízkých dávek cytosinu arabinoside (LD-AraC) vs LD-AraC plus granulocytů / makrofágů vs LD-AraC plus interleukinu-3 u MDS u pacientů s vysokým rizikem vývoje akutní leukémie. (cs) Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia (en)
skos:notation	RIV/00023736:_____/05:00007603!RIV09-MZ0-00023736
http://linked.open...avai/riv/aktivita	V
http://linked.open...avai/riv/aktivity	V
http://linked.open...iv/cisloPeriodika	11
http://linked.open...vai/riv/dodaniDat	2009
http://linked.open...aciTvurceVysledku	Čermák, Jaroslav
http://linked.open.../riv/druhVysledku	J - Článek v odborném periodiku
http://linked.open...iv/duvernostUdaju	S - Úplné a pravdivé údaje nepodléhající ochraně podle zvláštních právních předpisů
http://linked.open...titaPredkladatele	Ústav hematologie a krevní transfúze
http://linked.open...dnocenehoVysledku	528475
http://linked.open...ai/riv/idVysledku	RIV/00023736:_____/05:00007603
http://linked.open...riv/jazykVysledku	eng - angličtina
http://linked.open.../riv/klicovaSlova	EORTC Leukemia Cooperative Group; MDS (en)
http://linked.open.../riv/klicoveSlovo	MDS EORTC Leukemia Cooperative Group
http://linked.open...odStatuVydavatele	GB - Spojené království Velké Británie a Severního Irska
http://linked.open...ontrolniKodProRIV	[490D8C46CBEB]
http://linked.open...i/riv/nazevZdroje	Leukemia
http://linked.open...in/vavai/riv/obor	FD
http://linked.open...ichTvurcuVysledku	1 (xsd:int)
http://linked.open...cetTvurcuVysledku	13 (xsd:int)
http://linked.open...UplatneniVysledku	2005
http://linked.open...v/svazekPeriodika	19
http://linked.open...iv/tvurceVysledku	Neuwirtová, R. Čermák, Jaroslav Fenaux, P. Amadori, S. Suciu, S. Zwierzina, H. De Witte, T. M. Willemze, R. Beksac, M. Harousseau, J. Loeffler-Ragg, J. Nuessler, V. Solbu, G.
http://linked.open...ain/vavai/riv/wos	000232833100010
issn	0887-6924
number of pages	5 (xsd:int)
is http://linked.open...avai/riv/vysledek of	Low-dose cytosine arabinoside (LD-AraC) vs LD-AraC plus granulocyte/macrophage colony stimulating factor vs LD-AraC plus Interleukin-3 for myelodysplastic syndrome patients with a high risk of developing acute leukemia

Faceted Search & Find service v1.16.118 as of Jun 21 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software